Facilitation of macrophage-mediated destruction of allogeneic fibrosarcoma cells by tumor-enhancing IgG 2  in vitro.
D000818:Animals; D002277:Carcinoma / Q000276:immunology; D002460:Cell Line; D002478:Cells, Cultured; D002859:Chromium Isotopes; D003601:Cytotoxicity Tests, Immunologic; D005260:Female; D005354:Fibrosarcoma / Q000276:immunology*; D006084:Graft Rejection; D006801:Humans; D007104:Immune Adherence Reaction; D007106:Immune Sera; D007074:Immunoglobulin G / Q000494:pharmacology*; D007518:Isoantibodies; D008264:Macrophages / Q000276:immunology*; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D008815:Mice, Inbred Strains; D009062:Mouth Neoplasms / Q000276:immunology; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000276:immunology; D014184:Transplantation, Homologous
D002859:Chromium Isotopes; D007106:Immune Sera; D007074:Immunoglobulin G; D007518:Isoantibodies